Cargando…

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

BACKGROUND AND AIMS: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbedewy, Tamer A, Elsebaey, Mohamed A, Elshweikh, Samah A, Elashry, Heba, Abd-Elsalam, Sherief
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375108/ https://www.ncbi.nlm.nih.gov/pubmed/30804674 http://dx.doi.org/10.2147/TCRM.S186106

Ejemplares similares

Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
por: Elbedewy, Tamer A, et al.
Publicado: (2020)

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding
por: Elsebaey, Mohamed A., et al.
Publicado: (2018)

Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish, Fazal-i-Akbar, et al.
Publicado: (2013)

Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
por: Elsebaey, Mohamed A., et al.
Publicado: (2022)

Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2018)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Resistant thrombocytopenia in an HIV and hepatitis C patient: treatment response with novel agent eltrombopag
por: Vijayakrishnan, Rajakrishnan, et al.
Publicado: (2011)

Helicobacter pylori infection and risk of salmonella infection
por: Salama, Rasha I., et al.
Publicado: (2019)

Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018)

Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
por: Profit, Louise
Publicado: (2006)

Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2015)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016)

Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia
por: Maraziti, Giorgio, et al.
Publicado: (2021)

Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome
por: Xu, Liping, et al.
Publicado: (2022)

Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
por: Badawi, Rehab, et al.
Publicado: (2020)

Galectin-3 as a prognostic biomarker for diabetic nephropathy
por: Hodeib, Hossam, et al.
Publicado: (2019)

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
por: Tarantino, Michael D., et al.
Publicado: (2014)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
por: Özdemirkıran, Füsun, et al.
Publicado: (2015)

Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag
por: Nambiar, Vivek, et al.
Publicado: (2016)

Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
por: Bidika, Erjola, et al.
Publicado: (2020)

Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease
por: Wang, Juan, et al.
Publicado: (2021)

Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia
por: Di Paola, Alessandra, et al.
Publicado: (2020)

Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
por: Güven, Zeynep Tuğba, et al.
Publicado: (2022)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation
por: KARATAŞ, Ayşe, et al.
Publicado: (2022)

Eltrombopag Use in Thrombocytopenia for Endoscopic Submucosal Dissection of a Gastric Carcinoid
por: Kolb, Jennifer M., et al.
Publicado: (2014)

Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus
por: Shima, Natsuki, et al.
Publicado: (2018)

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial
por: Zaninetti, Carlo, et al.
Publicado: (2020)

Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia
por: Gruhn, Bernd, et al.
Publicado: (2021)

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis
por: Ahmed, Hafiz Abdul Waqas, et al.
Publicado: (2021)

Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
por: Weingarten, Sarah J., et al.
Publicado: (2020)

Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis
por: Patwardhan, Pallavi, et al.
Publicado: (2021)

Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report
por: Mohamed, Sabah E., et al.
Publicado: (2020)

The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
por: Yassin, Mohamed A, et al.
Publicado: (2022)

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qau1pn5bljogk76buv7oeed1fr